nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0697	0.127	CbGbCtD
Diclofenamide—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0638	0.116	CbGbCtD
Diclofenamide—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0593	0.108	CbGbCtD
Diclofenamide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0504	0.0916	CbGbCtD
Diclofenamide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0504	0.0916	CbGbCtD
Diclofenamide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0465	0.0845	CbGbCtD
Diclofenamide—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0449	0.0816	CbGbCtD
Diclofenamide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0411	0.0747	CbGbCtD
Diclofenamide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0382	0.0694	CbGbCtD
Diclofenamide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0366	0.0666	CbGbCtD
Diclofenamide—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0258	0.0469	CbGbCtD
Diclofenamide—CYP2C9—Losartan—type 2 diabetes mellitus	0.0236	0.0429	CbGbCtD
Diclofenamide—CA1—nerve—type 2 diabetes mellitus	0.00295	0.0871	CbGeAlD
Diclofenamide—CA9—islet of Langerhans—type 2 diabetes mellitus	0.00244	0.072	CbGeAlD
Diclofenamide—CA4—nerve—type 2 diabetes mellitus	0.00231	0.0681	CbGeAlD
Diclofenamide—CA7—kidney—type 2 diabetes mellitus	0.00197	0.058	CbGeAlD
Diclofenamide—CA5A—liver—type 2 diabetes mellitus	0.00187	0.0551	CbGeAlD
Diclofenamide—CA12—kidney—type 2 diabetes mellitus	0.00128	0.0377	CbGeAlD
Diclofenamide—CA5B—cardiovascular system—type 2 diabetes mellitus	0.00117	0.0346	CbGeAlD
Diclofenamide—CA5B—pancreas—type 2 diabetes mellitus	0.00114	0.0336	CbGeAlD
Diclofenamide—CA4—islet of Langerhans—type 2 diabetes mellitus	0.00112	0.033	CbGeAlD
Diclofenamide—CA14—liver—type 2 diabetes mellitus	0.00104	0.0305	CbGeAlD
Diclofenamide—CA1—cardiovascular system—type 2 diabetes mellitus	0.00103	0.0305	CbGeAlD
Diclofenamide—CA5B—adipose tissue—type 2 diabetes mellitus	0.00103	0.0305	CbGeAlD
Diclofenamide—CA1—kidney—type 2 diabetes mellitus	0.00101	0.0299	CbGeAlD
Diclofenamide—CA1—pancreas—type 2 diabetes mellitus	0.001	0.0297	CbGeAlD
Diclofenamide—CA2—islet of Langerhans—type 2 diabetes mellitus	0.000927	0.0273	CbGeAlD
Diclofenamide—CA1—adipose tissue—type 2 diabetes mellitus	0.000912	0.0269	CbGeAlD
Diclofenamide—CA4—nephron tubule—type 2 diabetes mellitus	0.0009	0.0266	CbGeAlD
Diclofenamide—CA4—cardiovascular system—type 2 diabetes mellitus	0.000808	0.0239	CbGeAlD
Diclofenamide—CA2—retina—type 2 diabetes mellitus	0.000792	0.0234	CbGeAlD
Diclofenamide—CA4—kidney—type 2 diabetes mellitus	0.000791	0.0233	CbGeAlD
Diclofenamide—CA4—cortex of kidney—type 2 diabetes mellitus	0.00077	0.0227	CbGeAlD
Diclofenamide—CA2—nephron tubule—type 2 diabetes mellitus	0.000746	0.022	CbGeAlD
Diclofenamide—CA4—adipose tissue—type 2 diabetes mellitus	0.000713	0.021	CbGeAlD
Diclofenamide—Confusional state—Glimepiride—type 2 diabetes mellitus	0.000707	0.00243	CcSEcCtD
Diclofenamide—Rash—Linagliptin—type 2 diabetes mellitus	0.000707	0.00243	CcSEcCtD
Diclofenamide—Headache—Linagliptin—type 2 diabetes mellitus	0.000702	0.00241	CcSEcCtD
Diclofenamide—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000694	0.00238	CcSEcCtD
Diclofenamide—Vomiting—Acarbose—type 2 diabetes mellitus	0.000692	0.00238	CcSEcCtD
Diclofenamide—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.000686	0.00236	CcSEcCtD
Diclofenamide—Rash—Acarbose—type 2 diabetes mellitus	0.000686	0.00236	CcSEcCtD
Diclofenamide—Tinnitus—Gliclazide—type 2 diabetes mellitus	0.000681	0.00234	CcSEcCtD
Diclofenamide—Drowsiness—Metformin—type 2 diabetes mellitus	0.000681	0.00234	CcSEcCtD
Diclofenamide—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.000674	0.00232	CcSEcCtD
Diclofenamide—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000673	0.00231	CcSEcCtD
Diclofenamide—Nausea—Tolazamide—type 2 diabetes mellitus	0.000673	0.00231	CcSEcCtD
Diclofenamide—CA2—cardiovascular system—type 2 diabetes mellitus	0.00067	0.0198	CbGeAlD
Diclofenamide—Anorexia—Glimepiride—type 2 diabetes mellitus	0.000668	0.0023	CcSEcCtD
Diclofenamide—Somnolence—Glipizide—type 2 diabetes mellitus	0.000668	0.0023	CcSEcCtD
Diclofenamide—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000667	0.00229	CcSEcCtD
Diclofenamide—Tremor—Glyburide—type 2 diabetes mellitus	0.000664	0.00228	CcSEcCtD
Diclofenamide—Rash—Nateglinide—type 2 diabetes mellitus	0.000661	0.00227	CcSEcCtD
Diclofenamide—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000661	0.00227	CcSEcCtD
Diclofenamide—CA2—kidney—type 2 diabetes mellitus	0.000656	0.0193	CbGeAlD
Diclofenamide—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000653	0.00224	CcSEcCtD
Diclofenamide—CA2—pancreas—type 2 diabetes mellitus	0.000651	0.0192	CbGeAlD
Diclofenamide—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000649	0.00223	CcSEcCtD
Diclofenamide—Nausea—Acarbose—type 2 diabetes mellitus	0.000646	0.00222	CcSEcCtD
Diclofenamide—Constipation—Glipizide—type 2 diabetes mellitus	0.000642	0.00221	CcSEcCtD
Diclofenamide—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000642	0.00221	CcSEcCtD
Diclofenamide—CA1—liver—type 2 diabetes mellitus	0.000639	0.0189	CbGeAlD
Diclofenamide—CA2—cortex of kidney—type 2 diabetes mellitus	0.000639	0.0188	CbGeAlD
Diclofenamide—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.000638	0.00219	CcSEcCtD
Diclofenamide—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000634	0.00218	CcSEcCtD
Diclofenamide—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000629	0.00216	CcSEcCtD
Diclofenamide—Pollakiuria—Losartan—type 2 diabetes mellitus	0.000627	0.00215	CcSEcCtD
Diclofenamide—Tension—Gliclazide—type 2 diabetes mellitus	0.000624	0.00215	CcSEcCtD
Diclofenamide—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000623	0.00214	CcSEcCtD
Diclofenamide—Nausea—Nateglinide—type 2 diabetes mellitus	0.000623	0.00214	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000621	0.00214	CcSEcCtD
Diclofenamide—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000621	0.00214	CcSEcCtD
Diclofenamide—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.00062	0.00213	CcSEcCtD
Diclofenamide—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000619	0.00213	CcSEcCtD
Diclofenamide—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000618	0.00212	CcSEcCtD
Diclofenamide—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000617	0.00212	CcSEcCtD
Diclofenamide—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000616	0.00212	CcSEcCtD
Diclofenamide—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000615	0.00211	CcSEcCtD
Diclofenamide—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000609	0.00209	CcSEcCtD
Diclofenamide—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000607	0.00209	CcSEcCtD
Diclofenamide—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000607	0.00209	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000605	0.00208	CcSEcCtD
Diclofenamide—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000604	0.00208	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000603	0.00207	CcSEcCtD
Diclofenamide—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000603	0.00207	CcSEcCtD
Diclofenamide—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000602	0.00207	CcSEcCtD
Diclofenamide—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.0006	0.00206	CcSEcCtD
Diclofenamide—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000598	0.00205	CcSEcCtD
Diclofenamide—Tremor—Gliclazide—type 2 diabetes mellitus	0.000596	0.00205	CcSEcCtD
Diclofenamide—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000593	0.00204	CcSEcCtD
Diclofenamide—CA2—adipose tissue—type 2 diabetes mellitus	0.000591	0.0174	CbGeAlD
Diclofenamide—Confusional state—Glyburide—type 2 diabetes mellitus	0.000583	0.002	CcSEcCtD
Diclofenamide—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000578	0.00199	CcSEcCtD
Diclofenamide—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000577	0.00198	CcSEcCtD
Diclofenamide—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000576	0.00198	CcSEcCtD
Diclofenamide—Rash—Repaglinide—type 2 diabetes mellitus	0.000572	0.00197	CcSEcCtD
Diclofenamide—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000569	0.00196	CcSEcCtD
Diclofenamide—Headache—Repaglinide—type 2 diabetes mellitus	0.000569	0.00196	CcSEcCtD
Diclofenamide—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000568	0.00195	CcSEcCtD
Diclofenamide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000567	0.00195	CcSEcCtD
Diclofenamide—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000567	0.0167	CbGeAlD
Diclofenamide—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000566	0.00195	CcSEcCtD
Diclofenamide—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000564	0.00194	CcSEcCtD
Diclofenamide—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000562	0.00193	CcSEcCtD
Diclofenamide—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000557	0.00191	CcSEcCtD
Diclofenamide—Anorexia—Glyburide—type 2 diabetes mellitus	0.000551	0.00189	CcSEcCtD
Diclofenamide—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.00055	0.00189	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000546	0.00188	CcSEcCtD
Diclofenamide—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000545	0.00187	CcSEcCtD
Diclofenamide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000541	0.00186	CcSEcCtD
Diclofenamide—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000541	0.00186	CcSEcCtD
Diclofenamide—Nausea—Repaglinide—type 2 diabetes mellitus	0.000539	0.00185	CcSEcCtD
Diclofenamide—Asthenia—Glipizide—type 2 diabetes mellitus	0.000539	0.00185	CcSEcCtD
Diclofenamide—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000538	0.00185	CcSEcCtD
Diclofenamide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000538	0.00185	CcSEcCtD
Diclofenamide—Pruritus—Glipizide—type 2 diabetes mellitus	0.000531	0.00183	CcSEcCtD
Diclofenamide—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000523	0.0018	CcSEcCtD
Diclofenamide—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000521	0.00179	CcSEcCtD
Diclofenamide—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000519	0.00178	CcSEcCtD
Diclofenamide—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000516	0.00177	CcSEcCtD
Diclofenamide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00051	0.00175	CcSEcCtD
Diclofenamide—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000509	0.00175	CcSEcCtD
Diclofenamide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000508	0.00175	CcSEcCtD
Diclofenamide—Tinnitus—Losartan—type 2 diabetes mellitus	0.000506	0.00174	CcSEcCtD
Diclofenamide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000503	0.00173	CcSEcCtD
Diclofenamide—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000503	0.00173	CcSEcCtD
Diclofenamide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000501	0.00172	CcSEcCtD
Diclofenamide—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.0005	0.00172	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000499	0.00172	CcSEcCtD
Diclofenamide—Tremor—Metformin—type 2 diabetes mellitus	0.000499	0.00171	CcSEcCtD
Diclofenamide—Dizziness—Glipizide—type 2 diabetes mellitus	0.000497	0.00171	CcSEcCtD
Diclofenamide—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000496	0.0017	CcSEcCtD
Diclofenamide—Tension—Irbesartan—type 2 diabetes mellitus	0.000493	0.00169	CcSEcCtD
Diclofenamide—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000488	0.00168	CcSEcCtD
Diclofenamide—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000484	0.00166	CcSEcCtD
Diclofenamide—Vomiting—Glipizide—type 2 diabetes mellitus	0.000478	0.00164	CcSEcCtD
Diclofenamide—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000476	0.00164	CcSEcCtD
Diclofenamide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000476	0.00164	CcSEcCtD
Diclofenamide—Rash—Glipizide—type 2 diabetes mellitus	0.000474	0.00163	CcSEcCtD
Diclofenamide—Headache—Glipizide—type 2 diabetes mellitus	0.000471	0.00162	CcSEcCtD
Diclofenamide—Tremor—Irbesartan—type 2 diabetes mellitus	0.000471	0.00162	CcSEcCtD
Diclofenamide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000467	0.00161	CcSEcCtD
Diclofenamide—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000466	0.0016	CcSEcCtD
Diclofenamide—Tension—Losartan—type 2 diabetes mellitus	0.000464	0.00159	CcSEcCtD
Diclofenamide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000464	0.00159	CcSEcCtD
Diclofenamide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000462	0.00159	CcSEcCtD
Diclofenamide—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000461	0.00159	CcSEcCtD
Diclofenamide—Nervousness—Losartan—type 2 diabetes mellitus	0.000459	0.00158	CcSEcCtD
Diclofenamide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000457	0.00157	CcSEcCtD
Diclofenamide—Anorexia—Valsartan—type 2 diabetes mellitus	0.000455	0.00156	CcSEcCtD
Diclofenamide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000454	0.00156	CcSEcCtD
Diclofenamide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000451	0.00155	CcSEcCtD
Diclofenamide—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00045	0.00155	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000448	0.00154	CcSEcCtD
Diclofenamide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000448	0.00154	CcSEcCtD
Diclofenamide—Nausea—Glipizide—type 2 diabetes mellitus	0.000446	0.00153	CcSEcCtD
Diclofenamide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000446	0.00153	CcSEcCtD
Diclofenamide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000444	0.00153	CcSEcCtD
Diclofenamide—Constipation—Gliclazide—type 2 diabetes mellitus	0.000444	0.00153	CcSEcCtD
Diclofenamide—Tremor—Losartan—type 2 diabetes mellitus	0.000443	0.00152	CcSEcCtD
Diclofenamide—Rash—Glimepiride—type 2 diabetes mellitus	0.000442	0.00152	CcSEcCtD
Diclofenamide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000441	0.00151	CcSEcCtD
Diclofenamide—Headache—Glimepiride—type 2 diabetes mellitus	0.000439	0.00151	CcSEcCtD
Diclofenamide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000438	0.0015	CcSEcCtD
Diclofenamide—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000434	0.00149	CcSEcCtD
Diclofenamide—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000428	0.00147	CcSEcCtD
Diclofenamide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000428	0.00147	CcSEcCtD
Diclofenamide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000425	0.00146	CcSEcCtD
Diclofenamide—Somnolence—Valsartan—type 2 diabetes mellitus	0.000424	0.00146	CcSEcCtD
Diclofenamide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000423	0.00145	CcSEcCtD
Diclofenamide—Leukopenia—Losartan—type 2 diabetes mellitus	0.000423	0.00145	CcSEcCtD
Diclofenamide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00042	0.00144	CcSEcCtD
Diclofenamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000418	0.00144	CcSEcCtD
Diclofenamide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000416	0.00143	CcSEcCtD
Diclofenamide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000415	0.00143	CcSEcCtD
Diclofenamide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000415	0.00143	CcSEcCtD
Diclofenamide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000415	0.00143	CcSEcCtD
Diclofenamide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000415	0.00143	CcSEcCtD
Diclofenamide—CA2—liver—type 2 diabetes mellitus	0.000414	0.0122	CbGeAlD
Diclofenamide—Anorexia—Metformin—type 2 diabetes mellitus	0.000414	0.00142	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000412	0.00142	CcSEcCtD
Diclofenamide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000411	0.00141	CcSEcCtD
Diclofenamide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00041	0.00141	CcSEcCtD
Diclofenamide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00041	0.00141	CcSEcCtD
Diclofenamide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000409	0.00141	CcSEcCtD
Diclofenamide—Constipation—Valsartan—type 2 diabetes mellitus	0.000408	0.0014	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000407	0.0014	CcSEcCtD
Diclofenamide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000406	0.0014	CcSEcCtD
Diclofenamide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000402	0.00138	CcSEcCtD
Diclofenamide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000401	0.00138	CcSEcCtD
Diclofenamide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000399	0.00137	CcSEcCtD
Diclofenamide—Tension—Ramipril—type 2 diabetes mellitus	0.000398	0.00137	CcSEcCtD
Diclofenamide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000396	0.00136	CcSEcCtD
Diclofenamide—Nervousness—Ramipril—type 2 diabetes mellitus	0.000394	0.00135	CcSEcCtD
Diclofenamide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000391	0.00134	CcSEcCtD
Diclofenamide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00039	0.00134	CcSEcCtD
Diclofenamide—Confusional state—Losartan—type 2 diabetes mellitus	0.000389	0.00134	CcSEcCtD
Diclofenamide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000388	0.00133	CcSEcCtD
Diclofenamide—Somnolence—Metformin—type 2 diabetes mellitus	0.000386	0.00133	CcSEcCtD
Diclofenamide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000382	0.00131	CcSEcCtD
Diclofenamide—Tremor—Ramipril—type 2 diabetes mellitus	0.00038	0.00131	CcSEcCtD
Diclofenamide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000378	0.0013	CcSEcCtD
Diclofenamide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000378	0.0013	CcSEcCtD
Diclofenamide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000376	0.00129	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000375	0.00129	CcSEcCtD
Diclofenamide—Fatigue—Metformin—type 2 diabetes mellitus	0.000374	0.00129	CcSEcCtD
Diclofenamide—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000373	0.00128	CcSEcCtD
Diclofenamide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000372	0.00128	CcSEcCtD
Diclofenamide—Constipation—Metformin—type 2 diabetes mellitus	0.000371	0.00128	CcSEcCtD
Diclofenamide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000368	0.00127	CcSEcCtD
Diclofenamide—Anorexia—Losartan—type 2 diabetes mellitus	0.000368	0.00126	CcSEcCtD
Diclofenamide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000368	0.00126	CcSEcCtD
Diclofenamide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000367	0.00126	CcSEcCtD
Diclofenamide—Rash—Glyburide—type 2 diabetes mellitus	0.000365	0.00125	CcSEcCtD
Diclofenamide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000364	0.00125	CcSEcCtD
Diclofenamide—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000363	0.00125	CcSEcCtD
Diclofenamide—Headache—Glyburide—type 2 diabetes mellitus	0.000362	0.00124	CcSEcCtD
Diclofenamide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000361	0.00124	CcSEcCtD
Diclofenamide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000358	0.00123	CcSEcCtD
Diclofenamide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000356	0.00122	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000354	0.00122	CcSEcCtD
Diclofenamide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000353	0.00121	CcSEcCtD
Diclofenamide—CYP2C9—liver—type 2 diabetes mellitus	0.000351	0.0103	CbGeAlD
Diclofenamide—Constipation—Irbesartan—type 2 diabetes mellitus	0.00035	0.0012	CcSEcCtD
Diclofenamide—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000346	0.00119	CcSEcCtD
Diclofenamide—Nausea—Glyburide—type 2 diabetes mellitus	0.000343	0.00118	CcSEcCtD
Diclofenamide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000343	0.00118	CcSEcCtD
Diclofenamide—Somnolence—Losartan—type 2 diabetes mellitus	0.000343	0.00118	CcSEcCtD
Diclofenamide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000342	0.00118	CcSEcCtD
Diclofenamide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00034	0.00117	CcSEcCtD
Diclofenamide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000338	0.00116	CcSEcCtD
Diclofenamide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000338	0.00116	CcSEcCtD
Diclofenamide—Pruritus—Valsartan—type 2 diabetes mellitus	0.000337	0.00116	CcSEcCtD
Diclofenamide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000335	0.00115	CcSEcCtD
Diclofenamide—Confusional state—Ramipril—type 2 diabetes mellitus	0.000333	0.00115	CcSEcCtD
Diclofenamide—Pruritus—Orlistat—type 2 diabetes mellitus	0.000333	0.00115	CcSEcCtD
Diclofenamide—Fatigue—Losartan—type 2 diabetes mellitus	0.000333	0.00114	CcSEcCtD
Diclofenamide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00033	0.00113	CcSEcCtD
Diclofenamide—Constipation—Losartan—type 2 diabetes mellitus	0.00033	0.00113	CcSEcCtD
Diclofenamide—Rash—Gliclazide—type 2 diabetes mellitus	0.000327	0.00113	CcSEcCtD
Diclofenamide—Headache—Gliclazide—type 2 diabetes mellitus	0.000325	0.00112	CcSEcCtD
Diclofenamide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000324	0.00111	CcSEcCtD
Diclofenamide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000324	0.00111	CcSEcCtD
Diclofenamide—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000318	0.00109	CcSEcCtD
Diclofenamide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000315	0.00108	CcSEcCtD
Diclofenamide—Anorexia—Ramipril—type 2 diabetes mellitus	0.000315	0.00108	CcSEcCtD
Diclofenamide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000312	0.00107	CcSEcCtD
Diclofenamide—Asthenia—Metformin—type 2 diabetes mellitus	0.000312	0.00107	CcSEcCtD
Diclofenamide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000308	0.00106	CcSEcCtD
Diclofenamide—Pruritus—Metformin—type 2 diabetes mellitus	0.000307	0.00106	CcSEcCtD
Diclofenamide—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000305	0.00105	CcSEcCtD
Diclofenamide—Vomiting—Valsartan—type 2 diabetes mellitus	0.000303	0.00104	CcSEcCtD
Diclofenamide—Rash—Valsartan—type 2 diabetes mellitus	0.000301	0.00103	CcSEcCtD
Diclofenamide—Vomiting—Orlistat—type 2 diabetes mellitus	0.0003	0.00103	CcSEcCtD
Diclofenamide—Headache—Valsartan—type 2 diabetes mellitus	0.000299	0.00103	CcSEcCtD
Diclofenamide—Rash—Orlistat—type 2 diabetes mellitus	0.000297	0.00102	CcSEcCtD
Diclofenamide—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000297	0.00102	CcSEcCtD
Diclofenamide—Headache—Orlistat—type 2 diabetes mellitus	0.000295	0.00101	CcSEcCtD
Diclofenamide—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000294	0.00101	CcSEcCtD
Diclofenamide—Somnolence—Ramipril—type 2 diabetes mellitus	0.000294	0.00101	CcSEcCtD
Diclofenamide—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000291	0.001	CcSEcCtD
Diclofenamide—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00029	0.000997	CcSEcCtD
Diclofenamide—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000288	0.000988	CcSEcCtD
Diclofenamide—Dizziness—Metformin—type 2 diabetes mellitus	0.000287	0.000987	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000286	0.000982	CcSEcCtD
Diclofenamide—Fatigue—Ramipril—type 2 diabetes mellitus	0.000285	0.00098	CcSEcCtD
Diclofenamide—Nausea—Valsartan—type 2 diabetes mellitus	0.000283	0.000974	CcSEcCtD
Diclofenamide—Constipation—Ramipril—type 2 diabetes mellitus	0.000283	0.000972	CcSEcCtD
Diclofenamide—Nausea—Orlistat—type 2 diabetes mellitus	0.00028	0.000962	CcSEcCtD
Diclofenamide—Asthenia—Losartan—type 2 diabetes mellitus	0.000277	0.000951	CcSEcCtD
Diclofenamide—Vomiting—Metformin—type 2 diabetes mellitus	0.000276	0.000949	CcSEcCtD
Diclofenamide—Rash—Metformin—type 2 diabetes mellitus	0.000274	0.000941	CcSEcCtD
Diclofenamide—Pruritus—Losartan—type 2 diabetes mellitus	0.000273	0.000938	CcSEcCtD
Diclofenamide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000273	0.000937	CcSEcCtD
Diclofenamide—Headache—Metformin—type 2 diabetes mellitus	0.000272	0.000935	CcSEcCtD
Diclofenamide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000271	0.000932	CcSEcCtD
Diclofenamide—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000261	0.000899	CcSEcCtD
Diclofenamide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000261	0.000896	CcSEcCtD
Diclofenamide—Rash—Irbesartan—type 2 diabetes mellitus	0.000258	0.000888	CcSEcCtD
Diclofenamide—Nausea—Metformin—type 2 diabetes mellitus	0.000258	0.000887	CcSEcCtD
Diclofenamide—Headache—Irbesartan—type 2 diabetes mellitus	0.000257	0.000883	CcSEcCtD
Diclofenamide—Dizziness—Losartan—type 2 diabetes mellitus	0.000255	0.000877	CcSEcCtD
Diclofenamide—Vomiting—Losartan—type 2 diabetes mellitus	0.000245	0.000843	CcSEcCtD
Diclofenamide—Nausea—Irbesartan—type 2 diabetes mellitus	0.000243	0.000837	CcSEcCtD
Diclofenamide—Rash—Losartan—type 2 diabetes mellitus	0.000243	0.000836	CcSEcCtD
Diclofenamide—Headache—Losartan—type 2 diabetes mellitus	0.000242	0.000831	CcSEcCtD
Diclofenamide—Asthenia—Ramipril—type 2 diabetes mellitus	0.000237	0.000816	CcSEcCtD
Diclofenamide—Pruritus—Ramipril—type 2 diabetes mellitus	0.000234	0.000804	CcSEcCtD
Diclofenamide—Nausea—Losartan—type 2 diabetes mellitus	0.000229	0.000788	CcSEcCtD
Diclofenamide—Dizziness—Ramipril—type 2 diabetes mellitus	0.000219	0.000752	CcSEcCtD
Diclofenamide—Vomiting—Ramipril—type 2 diabetes mellitus	0.00021	0.000723	CcSEcCtD
Diclofenamide—Rash—Ramipril—type 2 diabetes mellitus	0.000209	0.000717	CcSEcCtD
Diclofenamide—Headache—Ramipril—type 2 diabetes mellitus	0.000207	0.000712	CcSEcCtD
Diclofenamide—Nausea—Ramipril—type 2 diabetes mellitus	0.000196	0.000675	CcSEcCtD
Diclofenamide—CA9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.01e-05	0.000322	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CAT—type 2 diabetes mellitus	3.98e-05	0.000319	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.97e-05	0.000318	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.97e-05	0.000318	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—AGT—type 2 diabetes mellitus	3.96e-05	0.000318	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—INS—type 2 diabetes mellitus	3.93e-05	0.000315	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PPARG—type 2 diabetes mellitus	3.91e-05	0.000313	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PPARG—type 2 diabetes mellitus	3.91e-05	0.000313	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CALM1—type 2 diabetes mellitus	3.89e-05	0.000312	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GNB3—type 2 diabetes mellitus	3.89e-05	0.000312	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.89e-05	0.000312	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—APOE—type 2 diabetes mellitus	3.88e-05	0.000311	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—IL6—type 2 diabetes mellitus	3.87e-05	0.000311	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—HMOX1—type 2 diabetes mellitus	3.87e-05	0.00031	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.87e-05	0.00031	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—APOB—type 2 diabetes mellitus	3.87e-05	0.00031	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—APOA1—type 2 diabetes mellitus	3.84e-05	0.000308	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—INS—type 2 diabetes mellitus	3.83e-05	0.000307	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—INS—type 2 diabetes mellitus	3.83e-05	0.000307	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CAT—type 2 diabetes mellitus	3.82e-05	0.000306	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.8e-05	0.000305	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GCG—type 2 diabetes mellitus	3.8e-05	0.000305	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GSTM1—type 2 diabetes mellitus	3.76e-05	0.000302	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GNB3—type 2 diabetes mellitus	3.73e-05	0.000299	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.73e-05	0.000299	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—HMOX1—type 2 diabetes mellitus	3.71e-05	0.000297	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—APOB—type 2 diabetes mellitus	3.71e-05	0.000297	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—LPL—type 2 diabetes mellitus	3.69e-05	0.000296	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CAT—type 2 diabetes mellitus	3.66e-05	0.000294	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PPARG—type 2 diabetes mellitus	3.65e-05	0.000293	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PPARG—type 2 diabetes mellitus	3.65e-05	0.000293	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ADCY5—type 2 diabetes mellitus	3.61e-05	0.00029	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—ALB—type 2 diabetes mellitus	3.61e-05	0.000289	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GSTM1—type 2 diabetes mellitus	3.61e-05	0.000289	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GPX1—type 2 diabetes mellitus	3.6e-05	0.000289	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—INS—type 2 diabetes mellitus	3.58e-05	0.000287	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—INS—type 2 diabetes mellitus	3.58e-05	0.000287	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—APOB—type 2 diabetes mellitus	3.55e-05	0.000285	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—LPL—type 2 diabetes mellitus	3.54e-05	0.000284	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	3.53e-05	0.000283	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	3.53e-05	0.000283	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—ALB—type 2 diabetes mellitus	3.51e-05	0.000282	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—ALB—type 2 diabetes mellitus	3.51e-05	0.000282	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CD36—type 2 diabetes mellitus	3.51e-05	0.000281	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ADCY5—type 2 diabetes mellitus	3.47e-05	0.000278	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.46e-05	0.000278	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—BHMT—type 2 diabetes mellitus	3.46e-05	0.000277	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTM1—type 2 diabetes mellitus	3.46e-05	0.000277	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GPX1—type 2 diabetes mellitus	3.45e-05	0.000277	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PIK3R1—type 2 diabetes mellitus	3.45e-05	0.000277	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—NOS3—type 2 diabetes mellitus	3.45e-05	0.000277	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—LPL—type 2 diabetes mellitus	3.39e-05	0.000272	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PPARG—type 2 diabetes mellitus	3.38e-05	0.000271	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CD36—type 2 diabetes mellitus	3.36e-05	0.00027	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PIK3R1—type 2 diabetes mellitus	3.36e-05	0.00027	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.36e-05	0.00027	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—NOS3—type 2 diabetes mellitus	3.36e-05	0.00027	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—NOS3—type 2 diabetes mellitus	3.36e-05	0.00027	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—MTHFR—type 2 diabetes mellitus	3.32e-05	0.000267	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ADCY5—type 2 diabetes mellitus	3.32e-05	0.000266	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.32e-05	0.000266	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—INS—type 2 diabetes mellitus	3.32e-05	0.000266	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GPX1—type 2 diabetes mellitus	3.31e-05	0.000265	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—ALB—type 2 diabetes mellitus	3.28e-05	0.000263	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—ALB—type 2 diabetes mellitus	3.28e-05	0.000263	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GNB3—type 2 diabetes mellitus	3.28e-05	0.000263	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.28e-05	0.000263	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—HMOX1—type 2 diabetes mellitus	3.26e-05	0.000262	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PPARA—type 2 diabetes mellitus	3.26e-05	0.000261	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CD36—type 2 diabetes mellitus	3.22e-05	0.000259	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CAT—type 2 diabetes mellitus	3.22e-05	0.000258	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—MTHFR—type 2 diabetes mellitus	3.19e-05	0.000256	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.18e-05	0.000255	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—AGT—type 2 diabetes mellitus	3.16e-05	0.000253	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PTGS2—type 2 diabetes mellitus	3.15e-05	0.000253	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—NOS3—type 2 diabetes mellitus	3.14e-05	0.000252	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3R1—type 2 diabetes mellitus	3.14e-05	0.000252	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—NOS3—type 2 diabetes mellitus	3.14e-05	0.000252	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3R1—type 2 diabetes mellitus	3.14e-05	0.000252	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PPARA—type 2 diabetes mellitus	3.13e-05	0.000251	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—APOB—type 2 diabetes mellitus	3.12e-05	0.000251	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CALM1—type 2 diabetes mellitus	3.11e-05	0.000249	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—APOE—type 2 diabetes mellitus	3.09e-05	0.000248	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PTGS2—type 2 diabetes mellitus	3.07e-05	0.000247	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PTGS2—type 2 diabetes mellitus	3.07e-05	0.000247	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—APOA1—type 2 diabetes mellitus	3.06e-05	0.000245	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—MTHFR—type 2 diabetes mellitus	3.06e-05	0.000245	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTM1—type 2 diabetes mellitus	3.04e-05	0.000244	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—ALB—type 2 diabetes mellitus	3.04e-05	0.000244	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—AGT—type 2 diabetes mellitus	3.03e-05	0.000243	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTGDS—type 2 diabetes mellitus	3.02e-05	0.000242	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AANAT—type 2 diabetes mellitus	3.02e-05	0.000242	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PPARA—type 2 diabetes mellitus	3e-05	0.00024	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—LPL—type 2 diabetes mellitus	2.98e-05	0.000239	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CALM1—type 2 diabetes mellitus	2.98e-05	0.000239	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—APOE—type 2 diabetes mellitus	2.97e-05	0.000238	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—APOA1—type 2 diabetes mellitus	2.93e-05	0.000235	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ADCY5—type 2 diabetes mellitus	2.92e-05	0.000234	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GPX1—type 2 diabetes mellitus	2.91e-05	0.000233	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3R1—type 2 diabetes mellitus	2.91e-05	0.000233	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—NOS3—type 2 diabetes mellitus	2.91e-05	0.000233	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—AGT—type 2 diabetes mellitus	2.9e-05	0.000233	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	2.88e-05	0.000231	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PTGS2—type 2 diabetes mellitus	2.87e-05	0.00023	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PTGS2—type 2 diabetes mellitus	2.87e-05	0.00023	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CDO1—type 2 diabetes mellitus	2.87e-05	0.00023	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GPD2—type 2 diabetes mellitus	2.87e-05	0.00023	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CALM1—type 2 diabetes mellitus	2.85e-05	0.000229	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—APOE—type 2 diabetes mellitus	2.84e-05	0.000228	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CD36—type 2 diabetes mellitus	2.83e-05	0.000227	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—APOA1—type 2 diabetes mellitus	2.81e-05	0.000225	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	2.8e-05	0.000225	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.8e-05	0.000224	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	2.78e-05	0.000223	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	2.73e-05	0.000219	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	2.7e-05	0.000217	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PPARG—type 2 diabetes mellitus	2.7e-05	0.000216	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—MTHFR—type 2 diabetes mellitus	2.69e-05	0.000215	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PTGS2—type 2 diabetes mellitus	2.66e-05	0.000213	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—INS—type 2 diabetes mellitus	2.64e-05	0.000212	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PPARA—type 2 diabetes mellitus	2.64e-05	0.000211	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PPARG—type 2 diabetes mellitus	2.58e-05	0.000207	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—AGT—type 2 diabetes mellitus	2.55e-05	0.000205	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—INS—type 2 diabetes mellitus	2.53e-05	0.000203	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	2.52e-05	0.000202	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	2.52e-05	0.000202	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	2.51e-05	0.000202	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CALM1—type 2 diabetes mellitus	2.51e-05	0.000201	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—APOE—type 2 diabetes mellitus	2.5e-05	0.000201	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PPARG—type 2 diabetes mellitus	2.48e-05	0.000199	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—APOA1—type 2 diabetes mellitus	2.47e-05	0.000198	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	2.47e-05	0.000198	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.44e-05	0.000196	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	2.44e-05	0.000195	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	2.44e-05	0.000195	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	2.44e-05	0.000195	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	2.44e-05	0.000195	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.44e-05	0.000195	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—INS—type 2 diabetes mellitus	2.43e-05	0.000195	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ALB—type 2 diabetes mellitus	2.42e-05	0.000194	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	2.36e-05	0.000189	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ALB—type 2 diabetes mellitus	2.32e-05	0.000186	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—NOS3—type 2 diabetes mellitus	2.32e-05	0.000186	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.32e-05	0.000186	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	2.27e-05	0.000182	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	2.23e-05	0.000179	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	2.23e-05	0.000179	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ALB—type 2 diabetes mellitus	2.23e-05	0.000179	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—NOS3—type 2 diabetes mellitus	2.22e-05	0.000178	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.22e-05	0.000178	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PPARG—type 2 diabetes mellitus	2.18e-05	0.000175	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	2.17e-05	0.000174	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—INS—type 2 diabetes mellitus	2.14e-05	0.000171	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.13e-05	0.000171	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—NOS3—type 2 diabetes mellitus	2.13e-05	0.000171	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PTGS2—type 2 diabetes mellitus	2.12e-05	0.00017	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	2.07e-05	0.000166	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	2.07e-05	0.000166	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	2.07e-05	0.000166	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PTGS2—type 2 diabetes mellitus	2.03e-05	0.000163	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	1.99e-05	0.000159	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	1.99e-05	0.000159	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ALB—type 2 diabetes mellitus	1.96e-05	0.000157	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PTGS2—type 2 diabetes mellitus	1.95e-05	0.000156	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	1.91e-05	0.000153	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	1.91e-05	0.000153	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.88e-05	0.000151	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.88e-05	0.000151	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.87e-05	0.00015	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NOS3—type 2 diabetes mellitus	1.87e-05	0.00015	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.85e-05	0.000148	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.85e-05	0.000148	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.85e-05	0.000148	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.79e-05	0.000144	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.74e-05	0.000139	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PTGS2—type 2 diabetes mellitus	1.71e-05	0.000137	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.71e-05	0.000137	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.67e-05	0.000134	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.63e-05	0.00013	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.62e-05	0.00013	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—AKT1—type 2 diabetes mellitus	1.59e-05	0.000127	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.57e-05	0.000126	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.57e-05	0.000126	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.57e-05	0.000126	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.57e-05	0.000126	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—AKT1—type 2 diabetes mellitus	1.55e-05	0.000124	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—AKT1—type 2 diabetes mellitus	1.55e-05	0.000124	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.51e-05	0.000121	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	1.51e-05	0.000121	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.46e-05	0.000117	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—AKT1—type 2 diabetes mellitus	1.44e-05	0.000116	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—AKT1—type 2 diabetes mellitus	1.44e-05	0.000116	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.43e-05	0.000115	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.42e-05	0.000114	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	1.4e-05	0.000112	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—AKT1—type 2 diabetes mellitus	1.34e-05	0.000107	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.31e-05	0.000105	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.28e-05	0.000103	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.28e-05	0.000103	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.26e-05	0.000101	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.25e-05	0.0001	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.25e-05	0.0001	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.25e-05	0.0001	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.25e-05	0.0001	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.24e-05	9.94e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.22e-05	9.77e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.2e-05	9.65e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.12e-05	9e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.12e-05	8.97e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.12e-05	8.97e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.12e-05	8.97e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.1e-05	8.81e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.09e-05	8.73e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.07e-05	8.61e-05	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—AKT1—type 2 diabetes mellitus	1.07e-05	8.54e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.07e-05	8.54e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.02e-05	8.21e-05	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—AKT1—type 2 diabetes mellitus	1.02e-05	8.19e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.01e-05	8.12e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.01e-05	8.12e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	9.87e-06	7.91e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.82e-06	7.87e-05	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—AKT1—type 2 diabetes mellitus	9.8e-06	7.85e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	9.7e-06	7.78e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	9.7e-06	7.78e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—AKT1—type 2 diabetes mellitus	8.61e-06	6.9e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	8.36e-06	6.71e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.36e-06	6.71e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	8.33e-06	6.68e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	8.22e-06	6.59e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	7.98e-06	6.39e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	7.76e-06	6.22e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	7.62e-06	6.11e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	7.46e-06	5.98e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	7.43e-06	5.96e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	7.24e-06	5.8e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	7.14e-06	5.73e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	6.86e-06	5.5e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	6.73e-06	5.39e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	6.51e-06	5.22e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	6.41e-06	5.14e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	6.38e-06	5.12e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	6.31e-06	5.06e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	5.56e-06	4.46e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	5.45e-06	4.37e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	5e-06	4.01e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	4.78e-06	3.83e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	4.78e-06	3.83e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	4.37e-06	3.51e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.2e-06	1.76e-05	CbGpPWpGaD
